Showing results (1731-1740 of 1,762) with videos related to
Sort By:
Pageof 177
Journal of the American College of Cardiology|March 27, 2010
Intensive multifactorial intervention for stable coronary artery disease: optimal medical therapy in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trialDavid J Maron, William E Boden, Robert A O'Rourke, et al.International Journal of Hematology|July 15, 2022
Incidence and predictors of idiopathic pneumonia syndrome in hematopoietic stem cell transplant patients: a nationwide registry studyMichael A Liu, Chien-Chang Lee, Quan Phung, et al.Leukemia|June 9, 2017
Extended follow-up and impact of high-risk prognostic factors from the phase 3 RESONATE study in patients with previously treated CLL/SLLJ R Brown, P Hillmen, S O'Brien, et al.Annals of Hematology|January 23, 2019
The incidence and risk factors of hepatic veno-occlusive disease after hematopoietic stem cell transplantation in TaiwanChien-Chang Lee, Hsiu-Hao Chang, Meng-Yao Lu, et al.The New England Journal of Medicine|December 14, 2021
Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell LymphomaHervé Tilly, Franck Morschhauser, Laurie H Sehn, et al.International Journal of Hematology|February 25, 2022
NOVEL-1st: an observational study to assess the safety and efficacy of nilotinib in newly diagnosed patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase in TaiwanWen-Li Hwang, Tsung-Chih Chen, Hsuan-Yu Lin, et al.Cancer Letters|March 14, 2026
Identification of the MRTFA/SRF pathway as a critical regulator of quiescence and chemotherapy resistance in cancerSantiago Panesso-Gómez, Alexander J Cole, Austin Arrigo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 24, 2025
Five-Year Outcomes of the POLARIX Study Comparing Pola-R-CHP and R-CHOP in Patients With Diffuse Large B-Cell LymphomaFranck Morschhauser, Gilles Salles, Laurie H Sehn, et al.Arxiv|April 29, 2025
Go Figure: Transparency in neuroscience images preserves context and clarifies interpretationPaul A Taylor, Himanshu Aggarwal, Peter A Bandettini, et al.G3 (Bethesda, Md.)|November 6, 2016
The First Scube3 Mutant Mouse Line with Pleiotropic Phenotypic AlterationsHelmut Fuchs, Sibylle Sabrautzki, Gerhard K H Przemeck, et al.Pageof 177